What occurred

Shares of Veeva Programs (VEEV -14.00%) slumped on Thursday morning, falling as a lot as 16.5%. As of two:20 p.m. ET, the inventory was nonetheless down 16.3%.

The cloud supplier to the life sciences business introduced monetary outcomes that had been largely as anticipated, however its lackluster forecast spooked buyers.

So what

For the fiscal 2023 second quarter (ended July 31), Veeva reported income of $534.2 million, up 17% yr over yr, fueled by subscription-services income of $428.6 million, additionally up 17%. This resulted in non-GAAP earnings per share (EPS) of $1.03, a rise of 10%.  

Analysts’ consensus estimates had been calling for income of $530.7 million and EPS of $1.01, so Veeva beat on each counts.  

Administration mentioned the corporate made progress with each established and newly launched merchandise. “We’re early in a big and rising alternative,” mentioned CEO Peter Gassner, “and stay up for increasing our place because the strategic know-how companion to the life sciences business.”

The corporate famous that it achieved a significant milestone, with greater than 500 clients utilizing not less than one product within the Vault High quality Suite, pushed by a report 52 new buyer additions in the course of the quarter.

Now what

Administration lowered its outlook for the total fiscal yr, which doubtless sparked immediately’s sell-off. Veeva is now guiding for income of roughly $2.14 billion on the midpoint of its steering, which might signify progress of about 16% yr over yr, down from its earlier forecast of 17% progress. The corporate left its bottom-line steering largely unchanged, as Veeva expects adjusted EPS of $4.17, a rise of 12%.

On the convention name, CFO Brent Bowman identified that the practically half-the-guidance change was the results of a powerful greenback, which acts as a headwind for overseas forex translation. The remaining change was the results of slower adoption by small- and medium-sized companies. 

Veeva is the business chief and is effectively positioned for future progress. Moreover, whereas it has by no means been low cost, the inventory is at present buying and selling for simply 10 occasions subsequent yr’s gross sales, a valuation not seen since 2016. For buyers with the suitable investing time horizon, Veeva inventory continues to be a purchase.